Alto Neuroscience (ANRO) Shares Outstanding (2023 - 2026)

Alto Neuroscience has reported Shares Outstanding (Entity) for 4 years, with the latest figure at $35.1 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 29.48% year-over-year to $35.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.1 million (up 29.48% YoY) and the FY2025 annual result came in at $31.9 million, up 18.29% from the prior year.
• Shares Outstanding (Entity) grew to $35.1 million in Q1 2026 per ANRO's latest filing, from $31.9 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $35.1 million in Q1 2026 and troughed at $3.8 million in Q1 2023.
• A 4-year average of $20.2 million and a median of $27.0 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) soared 614.12% in 2024, then advanced 0.45% in 2025.
• Over 4 years, Shares Outstanding (Entity) stood at $3.8 million in 2023, then soared by 604.23% to $27.0 million in 2024, then gained by 18.29% to $31.9 million in 2025, then climbed by 9.8% to $35.1 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $35.1 million, $31.9 million, and $27.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.